Pyrroloquinoline quinone supplementation attenuates inflammatory liver injury by STAT3/TGF-β1 pathway in weaned piglets challenged with lipopolysaccharide

Caiyun Huang,Xuanci Yu,Chenyu Shi,Mengshi Wang,Ang Li,Fenglai Wang
DOI: https://doi.org/10.1017/s0007114523002970
2024-01-04
British Journal Of Nutrition
Abstract:This study is aimed to evaluate the effect and underling mechanism of dietary supplementation with pyrroloquinoline quinone disodium (PQQ) on improving inflammatory liver injury in piglets challenged with lipopolysaccharide (LPS). A total of 72 crossbred barrows were allotted into 4 groups as following: the CTRL group (basal diet + saline injection); the PQQ group (3 mg/kg PQQ diet + saline injection); the CTRL + LPS group (basal diet + LPS injection); and the PQQ + LPS group (3 mg/kg PQQ diet + LPS injection). On d 7, 11 and 14, piglets were challenged with LPS or saline. Blood was sampled at 4 hours after the last LPS injection (d 14), then the piglets were slaughtered and liver tissue were harvested. The results showed that the hepatic morphology was improved in the PQQ + LPS group compared with the CTRL + LPS group. PQQ supplementation decreased level of serum inflammatory factors, AST, ALT, and increased HDL-C concentration in piglets challenged with LPS; piglets in PQQ + LPS group had lower liver mRNA level of inflammatory factors and protein level of α-SMA than in CTRL + LPS group; Besides, mRNA expression of STAT3/TGF-β1 pathway and protein level of p-STAT3(Tyr 705) were decreased, and mRNA level of PPARα and protein expression of p-AMPK in liver were increased in PQQ + LPS group compared to CTRL + LPS group (P < 0.05). In conclusion, dietary supplementation with PQQ alleviated inflammatory liver injury might partly via inhibition of the STAT3/TGF-β1 pathway in piglets challenged with LPS.
nutrition & dietetics
What problem does this paper attempt to address?
This paper aims to explore the effects of Pyrroloquinoline Quinone (PQQ) supplements on liver inflammation damage induced by Lipopolysaccharide (LPS) challenge in weaned piglets and its potential mechanisms. Specifically, the researchers aim to address the following issues through the following experiments: 1. **Evaluate the effect of PQQ supplements**: The researchers aim to assess whether adding PQQ to the diet can improve liver inflammation damage induced by LPS challenge. 2. **Explore potential mechanisms**: The researchers aim to reveal how PQQ alleviates liver inflammation and fibrosis by inhibiting the STAT3/TGF-β1 signaling pathway through molecular biology and biochemical analysis. To achieve these goals, the researchers designed the following experiments: - **Experimental design**: 72 weaned piglets were randomly divided into 4 groups: - Control group (CTRL): basal diet + saline injection - PQQ group: 3 mg/kg PQQ diet + saline injection - Control + LPS group (CTRL + LPS): basal diet + LPS injection - PQQ + LPS group: 3 mg/kg PQQ diet + LPS injection - **Experimental process**: On days 7, 11, and 14, the piglets in the Control + LPS group and PQQ + LPS group received intraperitoneal injections of LPS, while the other groups received an equal amount of saline injection. Blood samples were collected 4 hours after the last LPS injection, and the piglets were slaughtered to obtain liver tissue. - **Detection indicators**: - **Liver tissue morphology**: Pathological changes in liver tissue were observed through HE staining and Masson's trichrome staining. - **Serum indicators**: Inflammatory factors (such as IL-1β, IL-17, IL-22), liver function indicators (such as AST, ALT), and blood lipid indicators (such as HDL-C) in the serum were detected. - **Gene expression**: The mRNA levels of related genes (such as IL-6, IL-17, STAT3, TGF-β1, Smad2, Smad3, Smad4, PPARα) in the liver were detected by qRT-PCR. - **Protein expression**: The expression levels of related proteins (such as IL-22, p-STAT3, α-SMA, p-AMPK) in the liver were detected by Western blot. Through these experiments, the researchers hope to verify whether PQQ supplements can alleviate LPS-induced liver inflammation and fibrosis by inhibiting the STAT3/TGF-β1 signaling pathway, thereby improving the liver health of piglets.